<!--
source: GPT-4o
abbr: GABA
sibs: gamma-aminobutyric-acid, dopamine, serotonin, acetylcholine
tags: neurotransmitters
-->

# Gamma-aminobutyric acid (GABA)

Gamma-aminobutyric acid (GABA) is a crucial neurotransmitter in the central nervous system that primarily functions as an inhibitory signal, reducing neuronal excitability throughout the nervous system. By binding to GABA receptors, it helps to calm neural activity, thereby regulating muscle tone, and promoting relaxation, sleep, and reducing anxiety.

GABA plays a significant role in maintaining the balance between excitation and inhibition in the brain, which is essential for proper brain function. An imbalance in GABA levels is associated with various neurological and psychiatric conditions. Low levels of GABA have been linked to anxiety disorders, depression, epilepsy, and insomnia. Conversely, enhancing GABA activity can have therapeutic effects, which is why many anxiolytic and anticonvulsant medications target GABAergic pathways.

The production of GABA occurs in GABAergic neurons through the decarboxylation of glutamate, facilitated by the enzyme glutamate decarboxylase. Once released, GABA binds to GABA receptors, including GABA_A and GABA_B receptors, which mediate its inhibitory effects. GABA_A receptors are ionotropic, allowing chloride ions to enter the neuron, leading to hyperpolarization and reduced neuronal firing. GABA_B receptors are metabotropic, working through G-proteins to produce longer-lasting inhibitory effects.

Understanding GABA's role in the brain is crucial for developing treatments for various disorders associated with GABAergic dysfunction. Research continues to explore how modulation of GABA activity can provide therapeutic benefits for conditions such as anxiety, epilepsy, and sleep disorders, highlighting its importance in neuropsychopharmacology.
